UBS Group
STXS icon

UBS Group’s Stereotaxis STXS Stock Holding History

UBS Group’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$437K Buy
237,278
+11,669
+5% +$25.6K ﹤0.01% 6176
2025
Q4 		$519K Buy
225,609
+141,721
+169% +$377K ﹤0.01% 6062
2025
Q3 		$261K Buy
83,888
+13,506
+19% +$35K ﹤0.01% 6513
2025
Q2 		$149K Buy
70,382
+34,646
+97% +$70.4K ﹤0.01% 6922
2025
Q1 		$62.9K Sell
35,736
-5,411
-13% -$11.5K ﹤0.01% 7402
2024
Q4 		$93.8K Buy
41,147
+28,504
+225% +$59.6K ﹤0.01% 6912
2024
Q3 		$25.8K Sell
12,643
-4,087
-24% -$8.23K ﹤0.01% 7216
2024
Q2 		$30.4K Sell
16,730
-4,951
-23% -$11.1K ﹤0.01% 7044
2024
Q1 		$56.6K Buy
21,681
+21,545
+15,842% +$51.2K ﹤0.01% 6456
2023
Q4 		$238 Sell
136
-2,530
-95% -$4.09K ﹤0.01% 8783
2023
Q3 		$4.21K Sell
2,666
-1,963
-42% -$3.14K ﹤0.01% 7466
2023
Q2 		$7.08K Buy
4,629
+4,493
+3,304% +$8.33K ﹤0.01% 7323
2023
Q1 		$277 Hold
136
– – ﹤0.01% 9102
2022
Q4 		$282 Sell
136
-81,641
-100% -$160K ﹤0.01% 10268
2022
Q3 		$147K Sell
81,777
-80,308
-50% -$172K ﹤0.01% 5373
2022
Q2 		$298K Sell
162,085
-38,894
-19% -$93K ﹤0.01% 4626
2022
Q1 		$749K Sell
200,979
-78,393
-28% -$370K ﹤0.01% 4371
2021
Q4 		$1.73M Buy
279,372
+45,277
+19% +$271K ﹤0.01% 3866
2021
Q3 		$1.26M Buy
234,095
+10,910
+5% +$82.3K ﹤0.01% 3992
2021
Q2 		$2.15M Sell
223,185
-106,700
-32% -$842K ﹤0.01% 3507
2021
Q1 		$2.22M Sell
329,885
-20,764
-6% -$123K ﹤0.01% 3467
2020
Q4 		$1.78M Buy
350,649
+52,331
+18% +$214K ﹤0.01% 3501
2020
Q3 		$1.07M Sell
298,318
-12,448
-4% -$48K ﹤0.01% 3587
2020
Q2 		$1.39M Buy
310,766
+193,522
+165% +$783K ﹤0.01% 3220
2020
Q1 		$354K Buy
117,244
+116,087
+10,033% +$480K ﹤0.01% 4275
2019
Q4 		$7K Sell
1,157
-337
-23% -$1.34K ﹤0.01% 7462
2019
Q3 		$5K Buy
+1,494
New +$5.74K ﹤0.01% 7489
2016
Q3 		– Sell
-23,835
Closed -$24K – 7921
2016
Q2 		$24K Buy
23,835
+16,036
+206% +$21.2K ﹤0.01% 6154
2016
Q1 		$8K Sell
7,799
-5,288
-40% -$4.52K ﹤0.01% 6796
2015
Q4 		$10K Buy
13,087
+4,308
+49% +$4.13K ﹤0.01% 7289
2015
Q3 		$8K Buy
8,779
+8,529
+3,412% +$8.44K ﹤0.01% 7423
2015
Q2 		$0 Sell
250
-8,384
-97% -$12.2K ﹤0.01% 8802
2015
Q1 		$14K Buy
8,634
+3,551
+70% +$5.66K ﹤0.01% 7360
2014
Q4 		$6K Buy
+5,083
New +$7.1K ﹤0.01% 8852

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group's STXS Position: Q1 2026 in Review

UBS Group increased its Stereotaxis (STXS) stake by 5.2% in Q1 2026, buying an estimated $25.6K and bringing the position to 237,278 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #6176.

UBS Group first reported a position in STXS in Q4 2014 and has held it in 34 quarters since. The position peaked at $2.22M in Q1 2021. 115 funds tracked by Wall St. Rank hold STXS as of Q1 2026.

  • UBS Group held 237,278 shares of Stereotaxis worth $437K as of Q1 2026.
  • UBS Group bought 11,669 Stereotaxis shares in Q1 2026, an estimated $25.6K.
  • Stereotaxis made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6176 holding.
  • UBS Group first reported a position in Stereotaxis in Q4 2014 and has held it in 34 quarters since.
  • UBS Group's Stereotaxis position peaked at $2.22M in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.